IAAG
GSK icon

Innovative Asset Advisors Group’s GSK GSK Stock Holding History

Innovative Asset Advisors Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,643
Closed -$91.3K – 592
2026
Q1 		$91.3K Buy
+1,643
New +$89K 0.05% 222

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Innovative Asset Advisors Group's GSK Position: Q2 2026 in Review

Innovative Asset Advisors Group sold out of GSK (GSK) in Q2 2026, closing a stake of 1,643 shares — an estimated $91.3K sold.

Innovative Asset Advisors Group first reported a position in GSK in Q1 2026 and held it in 1 quarter. The position peaked at $91.3K in Q1 2026. 999 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Innovative Asset Advisors Group reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Innovative Asset Advisors Group sold 1,643 GSK shares in Q2 2026, an estimated $91.3K.
  • Innovative Asset Advisors Group first reported a position in GSK in Q1 2026 and held it in 1 quarter.
  • Innovative Asset Advisors Group's GSK position peaked at $91.3K in Q1 2026.
  • 999 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Innovative Asset Advisors Group's 13F filing for Q2 2026, filed 5 Aug 2026.